Federated Hermes’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$986 Buy
+317
New +$986 ﹤0.01% 2001
2024
Q4
Sell
-551,398
Closed -$3.23M 2199
2024
Q3
$3.23M Sell
551,398
-2,816
-0.5% -$16.5K 0.01% 826
2024
Q2
$4.38M Buy
554,214
+2,638
+0.5% +$20.9K 0.01% 743
2024
Q1
$5.14M Hold
551,576
0.01% 723
2023
Q4
$4.66M Sell
551,576
-32,309
-6% -$273K 0.01% 749
2023
Q3
$4.53M Sell
583,885
-4,403
-0.7% -$34.1K 0.01% 720
2023
Q2
$6.74M Sell
588,288
-17,330
-3% -$198K 0.02% 633
2023
Q1
$4.67M Sell
605,618
-41
-0% -$316 0.01% 721
2022
Q4
$3.69M Sell
605,659
-136
-0% -$830 0.01% 743
2022
Q3
$3.59M Sell
605,795
-7,252
-1% -$42.9K 0.01% 746
2022
Q2
$3.62M Sell
613,047
-12,034
-2% -$71.1K 0.01% 771
2022
Q1
$4.76M Sell
625,081
-259
-0% -$1.97K 0.01% 794
2021
Q4
$1.7M Sell
625,340
-94,108
-13% -$255K ﹤0.01% 1095
2021
Q3
$1.89M Buy
719,448
+41,123
+6% +$108K ﹤0.01% 1060
2021
Q2
$2.8M Buy
678,325
+404,893
+148% +$1.67M 0.01% 993
2021
Q1
$1.29M Sell
273,432
-35,731
-12% -$168K ﹤0.01% 1277
2020
Q4
$2.21M Sell
309,163
-215
-0.1% -$1.54K ﹤0.01% 1024
2020
Q3
$3.3M Buy
309,378
+49,435
+19% +$527K 0.01% 834
2020
Q2
$3.28M Sell
259,943
-217,915
-46% -$2.75M 0.01% 828
2020
Q1
$4.37M Sell
477,858
-547,964
-53% -$5.01M 0.01% 667
2019
Q4
$14.3M Buy
1,025,822
+284,022
+38% +$3.96M 0.03% 513
2019
Q3
$12.8M Buy
741,800
+234,022
+46% +$4.03M 0.03% 487
2019
Q2
$13.8M Buy
507,778
+507,369
+124,051% +$13.8M 0.03% 471
2019
Q1
$8K Sell
409
-3,324
-89% -$65K ﹤0.01% 1907
2018
Q4
$35K Buy
3,733
+3,264
+696% +$30.6K ﹤0.01% 1694
2018
Q3
$9K Sell
469
-75
-14% -$1.44K ﹤0.01% 1975
2018
Q2
$11K Sell
544
-272
-33% -$5.5K ﹤0.01% 1895
2018
Q1
$15K Sell
816
-1,082
-57% -$19.9K ﹤0.01% 1812
2017
Q4
$32K Buy
+1,898
New +$32K ﹤0.01% 1713